Clinical Trials Logo

Hearing Loss clinical trials

View clinical trials related to Hearing Loss.

Filter by:

NCT ID: NCT05377359 Recruiting - Hearing Loss Clinical Trials

Lab Evaluation of Novel Hearing Aid Coupling Method

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Evaluation of different hearing aid coupling methods including two states of a novel coupling method and two traditional coupling methods.

NCT ID: NCT05376215 Completed - Hearing Loss Clinical Trials

A Comparison of Hearing Aid Fitting Methods

Start date: August 17, 2022
Phase: N/A
Study type: Interventional

This investigation will compare hearing aid fitting methods between self-fitting and clinician fitting approaches by using a standardized questionnaire to evaluate subjective hearing aid benefit.

NCT ID: NCT05372094 Completed - Hearing Loss Clinical Trials

Noise Reduction Preferences in Teenagers and Pre-teens

Start date: February 23, 2023
Phase: N/A
Study type: Interventional

Noise reduction preferences and blue tooth access to hearing aid streaming features will be evaluated in experienced hearing aid users age 10-17.

NCT ID: NCT05369598 Recruiting - Cochlear Implants Clinical Trials

Audiological and Quality of Life Outcomes of Anatomy Based Fitting in Patients Implanted by Robot Assisted Cochlear Implant Surgery (RACIS)

RACIS ABF
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated. This study will focus on patients that are already implanted with the HEARO robotic system.

NCT ID: NCT05365646 Recruiting - Hearing Loss Clinical Trials

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and validate methods to use hearing aids equipped with embedded sensors and artificial intelligence to assist in the assessment of fall risk and in the implementation of interventions aimed at reducing the risk of falling, as well as to improve speech intelligibility in quiet and in background noise, track physical activity, and social engagement. The investigators hope is that the knowledge that is generated through this study will ultimately translate to the clinical setting and will help reduce the likelihood that individuals experience a fall, and improve the quality of hearing in individuals who wear hearing aids.

NCT ID: NCT05356221 Recruiting - Hearing Loss Clinical Trials

Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors

BC112
Start date: April 11, 2022
Phase:
Study type: Observational

The study is a non-interventional, observational, cross-sectional, study on users of Ponto sound processors. The purpose of this study is to evaluate subjectively assessed hearing performance and satisfaction with Oticon Medical's sound processors fitted with the Genie Medical fitting software.

NCT ID: NCT05350046 Completed - Hearing Loss Clinical Trials

Development of Physical Activity Features for Ear-worn Devices

Start date: July 11, 2022
Phase: N/A
Study type: Interventional

This study incorporates data collection to aid in development of software features related to physical activity for users of ear-worn devices.

NCT ID: NCT05349981 Completed - Hearing Loss Clinical Trials

Lyric Self-replacement Clinical Investigation

Start date: July 29, 2022
Phase: N/A
Study type: Interventional

This study is designed to investigate the effectiveness and safety of the Phonak Lyric self-replacement procedure, as compared to the HCP-replacement procedure.

NCT ID: NCT05343026 Not yet recruiting - Clinical trials for Tinnitus, Subjective

Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the HA treatment group, and the other is the waiting list control (WLC) group which receives no interventions during this period.

NCT ID: NCT05337748 Completed - Hearing Loss Clinical Trials

Clinical Validation of the Lexie Lumen Hearing Aid

Start date: April 11, 2022
Phase: N/A
Study type: Interventional

More than half a billion people globally have hearing loss. Most hearing loss is sensorineural, meaning that the hearing loss is irreversible and requires rehabilitation. The majority of people with hearing loss have mild to moderate degrees, for which the most effective treatment options are hearing aids. Over the past few years, there have been many developments in hearing technology and the service delivery models in which they are supplied. Traditional hearing care models include several visits to a qualified hearing professional who must both perform diagnostics and prescribe hearing aids, which in the past has been the only way to obtain hearing aids. However, newer developments include forms of self-fitting hearing aids that enable a user to perform threshold measurements to determine the degree of hearing loss and automatically program and fine-tune hearing aids. These devices are now becoming available as direct-to-consumer (DTC) or over-the-counter (OTC) hearing aids. Furthermore, alternative care models have been suggested to bolster access and uptake of assistive technology for hearing loss. Regulations on DTC and OTC hearing aids are starting to come into effect. In 2017, the FDA Reauthorization Act of 2016 directed the FDA to create a category for OTC hearing aids for adults with perceived mild-to-moderate hearing loss. In October 2021, the FDA formally proposed a rule to establish the OTC hearing aid category as part of this process. These changes in regulations would mean that soon, many of these self-fitting devices will become available. In response to these changes in service delivery models, the hearX group recently developed the Lexie Lumen hearing aids that can perform in-situ hearing threshold estimations and automatically prescribe hearing aid gain settings that closely approximate the gold-standard NAL-NL2 fitting prescription. This study aims to evaluate whether the performance of the novel Lexie self-test and self-fitting hearing aid is equivalent to the same hearing aid programmed professionally by an audiologist using a professionally obtained audiogram.